The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7910598 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 22, 2011

Filed:

Mar. 05, 2007
Applicants:

Amala Kishan Kompella, Hyderabad, IN;

Bhujanga Rao Adibhatla Kali Satya, Hyderabad, IN;

Sreenivas Rachakonda, Hyderabad, IN;

Khadgapathi Podili, Hyderabad, IN;

Nannapaneni Venkaiah Chowdary, Hyderabad, IN;

Inventors:

Amala kishan Kompella, Hyderabad, IN;

Bhujanga rao Adibhatla Kali Satya, Hyderabad, IN;

Sreenivas Rachakonda, Hyderabad, IN;

Khadgapathi Podili, Hyderabad, IN;

Nannapaneni Venkaiah Chowdary, Hyderabad, IN;

Assignee:

Natco Pharma Limited, Hyderabad, IN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/04 (2006.01); C07D 401/14 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to novel intermediates useful for the preparation of novel phenylaminopyrimidine derivatives, novel phenylaminopyrimidine derivatives. Pharmaceutical composition containing the novel phenylaminopyrimidine derivatives and processes for their preparation. The invention particularly relates to novel Phenyl pyrimidine amine derivatives of the general formula (I). The novel compounds of the formula 1 can be used in the therapy of Chronic Myeloid Leukemia (CML). Since the IC; 191 values of these molecules are in the range 0.1 to 10.0 nm, these novel compounds are potentially useful for the treatment of CML.


Find Patent Forward Citations

Loading…